Effects of pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on the cardiovascular system in sheep

This publication has 12 references indexed in Scilit:

• Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain
  Neuroscience Letters, 1991
• Immunohistochemical localization of the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), in human and primate hypothalamus
  Peptides, 1991
• Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding
  Journal of Endocrinology, 1991
• Immunohistochemical Demonstration of a Novel Hypothalamic Peptide, Pituitary Adenylate Cyclase-Activating Polypeptide, in the Ovine Hypothalamus*
  Endocrinology, 1990
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
  Biochemical and Biophysical Research Communications, 1989
• Vasoactive Intestinal Peptide in the Heart^a
  Annals of the New York Academy of Sciences, 1988
• Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin on the human right atrium in vitro
  European Journal of Pharmacology, 1987
• The in vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart
  Regulatory Peptides, 1984
• Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology
  Peptides, 1984
• Vasoactive Intestinal Peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes
  Peptides, 1982